1. Bennett MC, Diamond DM, Parker WD, Stryker SL, Rose GM (1992) Inhibition of cytochrome oxidase impairs learning and hippocampal plasticity: a novel animal model of Alzheimer’s disease. In: Meyer EM, et al (eds) Treatment of dementias. Plenum Press, New York
2. Bevan P (1984) Effect of muscarinic ligands on the electrical activity recorded from the hippocampus: a quantitative approach. Br J Pharmacol 82: 431–440
3. Chalmers DT, Dewar D, Graham DI, Brooks DN, McCulloch J (1990) Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type. Proc Natl Acad Sci USA 87: 1352–1356
4. Christie JE, Shering A, Fergusen J, Glen AIM (1981) Physostigmine and arecholine: efffects of intravenous infusions in Alzheimer presenile dementia. Br J Psychiatry 138: 46–50
5. Cummings JL, Gorman DG, Shapira J (1993) Physostigmine ameliorates the delusions of Alzheimer’s disease. Biol Psychiatry 33: 536–541